Quick Summary:
In the evolving landscape of the healthcare sector, the global wound care biologics market has emerged as a critical segment, underpinned by rising prevalence of various ailments and the expanding geriatric population. Wound care biologics have revolutionized traditional wound treatments by harnessing plant-derived active biomolecules and active biological agents. These state-of-the-art solutions restore the natural repair mechanism, efficiently controlling infections and accelerating the healing process.
This report provides an invaluable and detailed insight into the field, charting the latest advancements ranging from skin substitutes, bio-membranes and hydroconductive dressings to the development of next-generation biologics. The analysis is supplemented by a comprehensive overview of market segmentation and competitive landscape. In a rapidly evolving market, this report positions its readers at the forefront of insights, aiding informed decision-making and strategic planning. Stay abreast of the latest trends and discover enlightened paths to invest in and benefit from the growing wound care biologics market.
The global wound care biologics market size reached US$ 1.9 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028.
Wound care biologics refer to drugs extracted or semi-synthesized from natural sources which are used for controlling and healing infections. Wound healing is a complex process involving inflammation, accumulation of fibrous tissue, deposition of collagen, formation of epithelial cell layers and other disruptions. Biologic wound healing treatments possess the ability to restore the natural repair mechanism through active biological agents. For instance, plant-derived active biomolecules with antimicrobial, anti-inflammatory or antioxidant properties have proven efficacious in advancing the wound-healing process. Some of the recent technological advancements made in the field of wound healing include skin substitutes, bio-membranes, scaffolds, hydroconductive dressings and biologics.
Chronic skin wounds can be caused due to burns, skin cancers, infections, trauma or an underlying medical condition such as diabetes. With the growing prevalence of these ailments along with the expanding geriatric population, there has been a rise in the demand for treatments that can accelerate wound healing and facilitate a speedy recovery. Along with this, several initiatives have been undertaken by governments across the globe to create awareness about the benefits of wound care biologics among patients. Apart from this, manufacturers are also developing next-generation, cost-effective and high-quality biologics to make them more accessible. Moreover, many research and healthcare centers are entering into partnerships to modernize wound care treatments and develop innovative drugs for healing wounds. For example, researchers are focusing on integrating antimicrobial compounds into the wound dressing itself. These materials combine traditional wound dressings such as hydrogels or foams with antimicrobial compounds such as betaine, silver, chitin, or polyhexamethylene biguanide.
Wound care biologics refer to drugs extracted or semi-synthesized from natural sources which are used for controlling and healing infections. Wound healing is a complex process involving inflammation, accumulation of fibrous tissue, deposition of collagen, formation of epithelial cell layers and other disruptions. Biologic wound healing treatments possess the ability to restore the natural repair mechanism through active biological agents. For instance, plant-derived active biomolecules with antimicrobial, anti-inflammatory or antioxidant properties have proven efficacious in advancing the wound-healing process. Some of the recent technological advancements made in the field of wound healing include skin substitutes, bio-membranes, scaffolds, hydroconductive dressings and biologics.
Chronic skin wounds can be caused due to burns, skin cancers, infections, trauma or an underlying medical condition such as diabetes. With the growing prevalence of these ailments along with the expanding geriatric population, there has been a rise in the demand for treatments that can accelerate wound healing and facilitate a speedy recovery. Along with this, several initiatives have been undertaken by governments across the globe to create awareness about the benefits of wound care biologics among patients. Apart from this, manufacturers are also developing next-generation, cost-effective and high-quality biologics to make them more accessible. Moreover, many research and healthcare centers are entering into partnerships to modernize wound care treatments and develop innovative drugs for healing wounds. For example, researchers are focusing on integrating antimicrobial compounds into the wound dressing itself. These materials combine traditional wound dressings such as hydrogels or foams with antimicrobial compounds such as betaine, silver, chitin, or polyhexamethylene biguanide.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global wound care biologics market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product, wound type, application and end-user.Breakup by Product:
- Biologic Skin Substitutes
- Human Donor Tissue-Derived Products
- Acellular Animal-Derived Products
- Biosynthetic Products
- Topical Agents
Breakup by Wound Type:
- Ulcers
- Diabetic Foot Ulcers
- Venous Ulcers
- Pressure Ulcers
- Others
- Surgical and Traumatic Wounds
- Burns
Breakup by Application:
- Acute Wound
- Chronic Wound
- Surgical Wound
Breakup by End-User:
- Hospitals
- ASCs
- Burn Centres and Wound Clinics
Breakup by Region:
- Asia Pacific
- Europe
- North America
- Middle East and Africa
- Latin America
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Smith & Nephew, Mölnlycke Health Care, Integra lifesciences, Osiris Therapeutics, Avita Medical, ConvaTec Group, Cytori Therapeutics, Mylan, Johnson & Johnson, Leap Therapeutics, Nuo Therapeutics, Mallinckrodt, Wright Medical, Mimedx Group and Solsys Medical, etc.Key Questions Answered in This Report:
- How has the global wound care biologics market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global wound care biologics industry?
- What has been the impact of COVID-19 on the global wound care biologics industry?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the wound type?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the global wound care biologics industry?
- What are the key driving factors and challenges in the global wound care biologics industry?
- What is the structure of the global wound care biologics industry and who are the key players?
- What is the degree of competition in the global wound care biologics industry?
Frequently Asked Questions about the Global Wound Care Biologics Market
What is the estimated value of the Global Wound Care Biologics Market?
What is the growth rate of the Global Wound Care Biologics Market?
What is the forecasted size of the Global Wound Care Biologics Market?
Who are the key companies in the Global Wound Care Biologics Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 146 |
| Published | July 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 1.9 Billion |
| Forecasted Market Value ( USD | $ 3.2 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
Table of Contents
1 Preface3 Executive Summary12 Value Chain Analysis14 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Wound Care Biologics Market
6 Market Breakup by Product
7 Market Breakup by Wound Type
8 Market Breakup by Application
9 Market Breakup by End-User
10 Market Breakup by Region
11 SWOT Analysis
13 Porter’s Five Forces Analysis
15 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Smith & Nephew
- Mölnlycke Health Care
- Integra lifesciences
- Osiris Therapeutics
- Avita Medical
- ConvaTec Group
- Cytori Therapeutics
- Mylan
- Johnson & Johnson
- Leap Therapeutics
- Nuo Therapeutics
- Mallinckrodt
- Wright Medical
- Mimedx Group
- Solsys Medical
Methodology
LOADING...
